Staphylococcus aureus toxin antibodies: Good companions of antibiotics and vaccines

References

• Fattom A, Matalon A, Buerkert J, Taylor K, Damaso S, Boutriau D. Efficacy profile of a bivalent Staphylococcus aureus glycoconjugated vaccine in adults on hemodialysis: Phase III randomized study. Hum Vaccin Immunother 2015; 11(3):632-41; PMID:25483694; http://dx.doi.org/10.4161/hv.34414
   PubMed Web of Science ®Google Scholar
• Allen KB, Fowler VG Jr, Gammie JS, Hartzel JS, Onorato MT, DiNubile MJ, Sobanjo-Ter Meulen A. Staphylococcus aureus infections after elective cardiothoracic surgery: Observations from an international randomized Placebo-Controlled trial of an investigational S aureus vaccine. Open Forum Infect Dis 2014; 1(2):ofu071; PMID: 25734141; http://dx.doi.org/10.1093/ofid/ofu071
   PubMedGoogle Scholar
• Pozzi C., Lofano G, Mancini F, Soldaini E, Speziale P, De Gregorio E, Rappuoli R, Bertholet S, Grandi G, Bagnoli F et al. Phagocyte subsets and lymphocyte clonal deletion behind ineffective immune response to Staphylococcus aureus. FEMS Microbiol Rev 2015; 39(5):750-63; PMID: 25994610; http://dx.doi.org/10.1093/femsre/fuv024
   PubMed Web of Science ®Google Scholar
• Bagnoli F, Bertholet S, Grandi G. Inferring reasons for the failure of Staphylococcus aureus vaccines in clinical trials. Front Cell Infect Microbiol 2012; 2:16; PMID: 22919608; http://dx.doi.org/10.3389/fcimb.2012.00016
   PubMed Web of Science ®Google Scholar
• Yeaman MR, Filler SG, Schmidt CS, Ibrahim AS, Edwards JE Jr., Hennessey JP Jr Applying convergent immunity to innovative vaccines targeting Staphylococcus aureus. Front Immunol 2014; 5:463; PMID: 25309545; http://dx.doi.org/10.3389/fimmu.2014.00463
   PubMed Web of Science ®Google Scholar
• Bagnoli F, Fontana MR, Soldaini E, Mishra RP, Fiaschi L, Cartocci E, Nardi-Dei V, Ruggiero P, Nosari S, De Falco MG et al. Vaccine composition formulated with a novel TLR7-dependent adjuvant induces high and broad protection against Staphylococcus aureus. Proc Natl Acad Sci U S A 2015; 112(12):3680-5; PMID: 25775551
   PubMed Web of Science ®Google Scholar
• Miller LS, Cho JS. Immunity against Staphylococcus aureus cutaneous infections. Nat Rev Immunol 2011; 11(8):505-18; PMID: 21720387; http://dx.doi.org/10.1038/nri3010
   PubMed Web of Science ®Google Scholar
• Hua L, Cohen TS, Shi Y, Datta V, Hilliard JJ, Tkaczyk C, Suzich J, Stover CK, Sellman BR. MEDI4893* promotes survival and extends the antibiotic treatment window in a Staphylococcus aureus Immunocompromised Pneumonia Model. Antimicrob Agents Chemother 2015; 59(8):4526-32; PMID: 25987629; http://dx.doi.org/10.1128/AAC.00510-15
   PubMed Web of Science ®Google Scholar
• Rouha H, Badarau A, Visram ZC, Battles MB, Prinz B, Magyarics Z, Nagy G, Mirkina I, Stulik L, Zerbs M et al. Five birds, one stone: neutralization of alpha-hemolysin and 4 bi-component leukocidins of Staphylococcus aureus with a single human monoclonal antibody. MAbs 2015; 7(1):243-54; PMID: 25523282; http://dx.doi.org/10.4161/19420862.2014.985132
   PubMed Web of Science ®Google Scholar
• Badarau A, Rouha H, Malafa S, Battles MB, Walker L, Nielson N, Dolezilkova I, Teubenbacher A, Banerjee S, Maierhofer B et al. Context matters: The importance of dimerization-induced conformation of the LukGH leukocidin of Staphylococcus aureus for the generation of neutralizing antibodies. MAbs 2016; 8(7):1347-1360; PMID: 27467113; http://dx.doi.org/10.1080/19420862.2016.1215791
   PubMed Web of Science ®Google Scholar
• Chon JH, Zarbis-Papastoitsis G. Advances in the production and downstream processing of antibodies. N Biotechnol 2011; 28(5):458-63; PMID: 21515428; http://dx.doi.org/10.1016/j.nbt.2011.03.015
   PubMed Web of Science ®Google Scholar
• Shukla AA, Thommes J. Recent advances in large-scale production of monoclonal antibodies and related proteins. Trends Biotechnol 2010; 28(5):253-61; PMID: 20304511; http://dx.doi.org/10.1016/j.tibtech.2010.02.001
   PubMed Web of Science ®Google Scholar
• Diem MD, Hyun L, Yi F, Hippensteel R, Kuhar E, Lowenstein C, Swift EJ, O'Neil KT, Jacobs SA. Selection of high-affinity Centyrin FN3 domains from a simple library diversified at a combination of strand and loop positions. Protein Eng Des Sel 2014; 27(10):419-29; PMID: 24786107; http://dx.doi.org/10.1093/protein/gzu016
   PubMed Web of Science ®Google Scholar
• Chen WH, Pasetti MF, Adhikari RP, Baughman H, Douglas R, El-Khorazaty J, Greenberg N, Holtsberg FW, Liao GC, Reymann MK et al. Safety and immunogenicity of a parenterally administered, Structure-Based rationally modified recombinant Staphylococcal Enterotoxin B Protein Vaccine, STEBVax. Clin Vaccine Immunol 2016; 23(12):918-925; PMID: 27707765; http://dx.doi.org/10.1128/CVI.00399-16
   PubMed Web of Science ®Google Scholar
• Krakauer T, Stiles BG. The staphylococcal enterotoxin (SE) family: SEB and siblings. Virulence 2013; 4(8):759-73; PMID: 23959032; http://dx.doi.org/10.4161/viru.23905
   PubMed Web of Science ®Google Scholar
• Karau MJ, Tilahun ME, Krogman A, Osborne BA, Goldsby RA, David CS, Mandrekar JN, Patel R, Rajagopalan G. Passive therapy with humanized anti-staphylococcal enterotoxin B antibodies attenuates systemic inflammatory response and protects from lethal pneumonia caused by staphylococcal enterotoxin B-producing Staphylococcus aureus. Virulence 2016; 1-12; PMID: 27925510; http://dx.doi.org/10.1080/21505594.2016.1267894
   PubMed Web of Science ®Google Scholar
• Tilahun ME, Rajagopalan G, Shah-Mahoney N, Lawlor RG, Tilahun AY, Xie C, Natarajan K, Margulies DH, Ratner DI, Osborne BA et al. Potent neutralization of staphylococcal enterotoxin B by synergistic action of chimeric antibodies. Infect Immun 2010; 78(6):2801-11; PMID: 20308304; http://dx.doi.org/10.1128/IAI.01121-09
   PubMed Web of Science ®Google Scholar
• Tilahun ME, Kwan A, Natarajan K, Quinn M, Tilahun AY, Xie C, Margulies DH, Osborne BA, Goldsby RA, Rajagopalan G et al. Chimeric anti-staphylococcal enterotoxin B antibodies and lovastatin act synergistically to provide in vivo protection against lethal doses of SEB. PLoS One 2011; 6(11):e27203; PMID: 22102880; http://dx.doi.org/10.1371/journal.pone.0027203
   PubMed Web of Science ®Google Scholar
• DaSilva L, Welcher BC, Ulrich RG, Aman MJ, David CS, Bavari S. Humanlike immune response of human leukocyte antigen-DR3 transgenic mice to staphylococcal enterotoxins: a novel model for superantigen vaccines. J Infect Dis 2002; 185(12):1754-60; PMID: 12085321; http://dx.doi.org/10.1086/340828
   PubMed Web of Science ®Google Scholar
• Fraser JD. High-affinity binding of staphylococcal enterotoxins A and B to HLA-DR. Nature 1989; 339(6221):221-3; PMID: 2785644; http://dx.doi.org/10.1038/339221a0
   PubMed Web of Science ®Google Scholar
• Hua L, Hilliard JJ, Shi Y, Tkaczyk C, Cheng LI, Yu X, Datta V, Ren S, Feng H, Zinsou R et al. Assessment of an anti-alpha-toxin monoclonal antibody for prevention and treatment of Staphylococcus aureus-induced pneumonia. Antimicrob Agents Chemother 2014; 58(2):1108-17; PMID: 24295977; http://dx.doi.org/10.1128/AAC.02190-13
   PubMed Web of Science ®Google Scholar
• Brosnahan AJ, Mantz MJ, Squier CA, Peterson ML, Schlievert PM. Cytolysins augment superantigen penetration of stratified mucosa. J Immunol 2009; 182(4):2364-73; PMID: 19201891; http://dx.doi.org/10.4049/jimmunol.0803283
   PubMed Web of Science ®Google Scholar
• Wunderink RG, Niederman MS, Kollef MH, Shorr AF, Kunkel MJ, Baruch A, McGee WT, Reisman A, Chastre J. Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. Clin Infect Dis 2012; 54(5):621-9; PMID: 22247123; http://dx.doi.org/10.1093/cid/cir895
   PubMed Web of Science ®Google Scholar
• Holmes NE, Tong SY, Davis JS, van Hal SJ. Treatment of methicillin-resistant Staphylococcus aureus: vancomycin and beyond. Semin Respir Crit Care Med 2015; 36(1):17-30; PMID: 25643268; http://dx.doi.org/10.1055/s-0034-1397040
   PubMed Web of Science ®Google Scholar
• Rubinstein E, Lalani T, Corey GR, Kanafani ZA, Nannini EC, Rocha MG, Rahav G, Niederman MS, Kollef MH, Shorr AF et al. Telavancin versus vancomycin for hospital-acquired pneumonia due to gram-positive pathogens. Clin Infect Dis 2011; 52(1):31-40; PMID: 21148517; http://dx.doi.org/10.1093/cid/ciq031
   PubMed Web of Science ®Google Scholar
• Lehar SM, Pillow T, Xu M, Staben L, Kajihara KK, Vandlen R, DePalatis L, Raab H, Hazenbos WL, Morisaki JH et al. Novel antibody-antibiotic conjugate eliminates intracellular S. aureus. Nature 2015; 527(7578):323-8; PMID: 26536114; http://dx.doi.org/10.1038/nature16057
   PubMed Web of Science ®Google Scholar
• Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis 2008; 197(8):1079-81; PMID: 18419525; http://dx.doi.org/10.1086/533452
   PubMed Web of Science ®Google Scholar